Muilenberg v. Upjohn Co.
Decision Date | 11 June 1982 |
Docket Number | Docket No. 50216 |
Citation | 320 N.W.2d 358,115 Mich.App. 316 |
Parties | Terry MUILENBERG and Marvin Muilenberg, Plaintiffs-Appellees, v. The UPJOHN COMPANY, a Delaware corporation, Defendant-Appellant. |
Court | Court of Appeal of Michigan — District of US |
Macarthur & Cheatham, P. C., Thomas H. Bleakley, P. C., and Gromek, Bendure & Thomas by James G. Gross, Detroit, for plaintiffs-appellees.
Cholette, Perkins & Buchanan by Grant J. Gruel, Grand Rapids, for defendant-appellant.
Before ALLEN, P. J., and R. B. BURNS and J. H. GILLIS, JJ.
A jury verdict of $750,000 was rendered in favor of plaintiff Terry Muilenberg 1 in this products liability action. The action stemmed from plaintiff's ingestion of a drug, Cleocin, produced and distributed by defendant Upjohn Company. The theories of the case were failure to warn of the drug's side effects and negligence by Upjohn in the pretesting of the drug.
On July 22, 1971, plaintiff went to Dr. Harrell, a dermatologist at the University of Michigan Medical Center, for treatment of acne. The drug Cleocin was prescribed for treatment. The label on the drug, at that time, did not indicate that colitis possibly was a side effect of the medication.
Plaintiff was instructed by Dr. Harrell to take the medication two times a day. Approximately three days after plaintiff started taking the drug he experienced bleeding and diarrhea. Prior to ingestion of the drug, plaintiff had complained of rectal bleeding. He consulted a doctor, who diagnosed the problem as hemorrhoids. At that point plaintiff had not experienced the extreme stomach cramping and diarrhea which occurred while he took Cleocin.
Plaintiff was sickly, weakened from the diarrhea. Finally, on August 1, 1971, his family contacted their physician, Dr. Howie who instructed plaintiff to discontinue using Cleocin. Later that same day plaintiff went to the emergency room of Blodgett Hospital. On August 9, 1971, he consulted Dr. Benjamin, who instructed plaintiff to check into the hospital. He remained in the hospital four weeks. When the colitis condition subsided, he was released from the hospital and recuperated at home an additional two weeks. He returned to the hospital in September, 1971, and in April, 1972, for blood transfusions, required because of the bloody diarrhea. After constant medical attention, in January, 1973, plaintiff underwent a colectomy and ileostomy to alleviate his condition of severe chronic ulcerative colitis.
Several issues are raised on appeal in this complex products liability case. First, the defendant claims prejudicial error occurred when plaintiff's counsel, before the jury, during the rebuttal argument, referred to the trial court's denial of defendant's motion for a directed verdict. Plaintiff's counsel's argument, defendant proposed, insinuated that the denial of the motion for a directed verdict was proof of defendant's negligence.
During rebuttal argument plaintiff's counsel addressed the jury as follows:
Plaintiff concedes that the argument was improper, but argues no reversible error occurred, especially where the court gave a cautionary instruction on the reference to the directed verdict motion. Further, plaintiff argues that the remark, if prejudicial, is not per se cause for reversal unless deliberately and continuously made.
The trial court instructed the jury:
Generally, it is improper for counsel to highlight to the jury that the opposing party's motion for a directed verdict was denied. See Robelen Piano Co. v. DiFonzo, 53 Del. 346, 169 A.2d 240 (1961); Sanchez v. Stremel, 95 Ariz. 392, 391 P.2d 557 (1964); Daly v. Pere Marquette R. Co., 197 Mich. 340, 163 N.W. 883 (1917). In order to determine the prejudicial impact of the statement the substance of the curative instruction, where the trial court gave one, must be analyzed. In 10 ALR3d 1330, 1332, it is stated:
"Thus, under ordinary circumstances, and in the absence of corrective action by the trial judge sufficient to obviate the effects of such an argument, it is generally held that resort to such tactics by counsel prejudices the rights of the opposing party, necessitating reversal or a new trial." (Emphasis added.)
Upon close scrutiny of the instruction, we find it did not obviate the prejudicial impact of the plaintiff's counsel's statement. In Willett v. Ford Motor Co., 400 Mich. 65, 253 N.W.2d 111 (1977), where the trial judge granted a new trial even though he previously had given a cautionary instruction to the jury in reference to the argument of plaintiff's counsel, the Supreme Court made it clear that just any curative instruction would not be sufficient to eradicate improper arguments. The Court stated:
"The giving of a cautionary instruction does not preclude further relief from an unjust verdict if the trial judge, or reviewing court on appeal, finds that under all the circumstances the instruction may not have prevented the feared prejudicial impact. In granting a new trial for the plaintiff in Lapasinskas v Quick, 17 Mich App 733, 739, 170 NW2d 318 (1969), then-Judge Levin stated:
" " Willett, supra, 72, 253 N.W.2d 111.
Here, the Court, rather than negate the reference to the directed verdict, added credence to the insinuation that the judge believed there was evidence to support plaintiff's case. The instruction failed to advise the jury that the motion for a directed verdict had no bearing on the issue of defendant's negligence. Instead, the curative instruction focused on the fact that the judge had ruled on the law, and that was his province, not to be of concern to the jury since if his decision was erroneous the higher court would reverse it. This curative instruction did not discount the impact of the plaintiff's statement but to the contrary may have endorsed the plaintiff's argument in the juror's minds. As stated in Robelen Piano Co. v. DiFonzo, supra, 361, 169 A.2d at 248, where plaintiff's counsel argued that if there was not a case they wouldn't be before the jury, we think the Court should have been more positive in its instructions to the jury and should have admonished counsel as to the impropriety of the argument.
Since a general verdict was returned we have no way of knowing if the impact of the prejudicial remark was erased. See Willett, supra. On the face of the instruction, we cannot conclude that the potential prejudice to defendant's case from the comment was cured.
Next, defendant contests the admission of several exhibits into evidence. Defendant argues that letters transmitted between Upjohn and a doctor who conducted a study of the side effects of Cleocin for Upjohn should have been excluded pursuant to MRE 407, which guards against the admission into evidence of subsequent remedial measures.
During 1973-1974, more than two years after plaintiff's illness, Dr. Tedesco, Chief of Gastroenterology at the Medical College of Georgia, conducted a...
To continue reading
Request your trial-
Certified Questions From U.S. Dist. Court For Eastern Dist. of Mich., Southern Div., In re, Docket Nos. 68958
...336 N.W.2d 3 (1983); Dunn v. Lederle Laboratories, 121 Mich.App. 73, 79, 328 N.W.2d 576 (1982). See also Muilenberg v. Upjohn Co., 115 Mich.App. 316, 332, 320 N.W.2d 358 (1982); Formella v. Ciba-Geigy Corp., 100 Mich.App. 649, 655-656, 300 N.W.2d 356 (1980).1 The Squibb dictum has been cite......
-
May v. Parke, Davis & Co.
...proximately resulting from defendant's negligence. Clark v. Dalman, 379 Mich. 251, 150 N.W.2d 755 (1967); Muilenberg v. The Upjohn Co., 115 Mich.App. 316, 330, 320 N.W.2d 358 (1982). A plaintiff must present proof on each of these four elements to establish a prima facie case. Beals v. Walk......
-
Schutte v. Celotex Corp., Docket No. 123691
...resulted in the product not being used or other appropriate action being taken to heed the warning. In Muilenberg v. Upjohn Co., 115 Mich.App. 316, 332-333, 320 N.W.2d 358 (1982), the doctor who had prescribed the defendant manufacturer's drug for the plaintiff testified that he had not bee......
-
People v. Safiedine
...because of the systems employed in recording them and the reliance placed upon them by the business world. Muilenberg v. Upjohn Co, 115 Mich.App. 316, 327, 320 N.W.2d 358 (1982). With regard to the Mobil Oil Company records, the testimony of Charles J. Rullo, a district sales manager, estab......
-
Emerging DTC advertising of prescription drugs and the learned intermediary doctrine: even in the absence of a true physician-patient relationship, drug manufacturers can protect themselves by warning consumers directly.
...Inc. v. Cornish, 370 F.2d 82 (8th Cir. 1966); Wooderson v. Ortho Pharm. Corp., 681 P.2d 1038 (Kan. 1984). (8.) Muilenberg v. Upjohn Co., 320 N.W.2d 358 (Mich. App. 1982); Stanback v. Parke Davis & Co., 502 F.Supp. 767 (W.D. Va. 1980); Wheat v. Sofamor S.N.C., 46 F.Supp.2d 1351 (N.D. Ga.......